Shares of Takeda Pharmaceuticals rose after the Japanese pharmaceutical major announced positive results from clinical trials of its new treatment for plaque psoriasis. The stock climbed 4.3% in early ...

The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...

Tryptamine Therapeutics ( ($AU:ENP) ) has shared an update. Entropy Neurodynamics has received an $847,186 cash refund under Australia’s R&D Tax ...

Research suggests certain medications could help build or maintain muscle during weight loss. Here's how they work & how to ...

Orforglipron helped keep weight down when used after initial therapy with an injectable, a new treatment strategy that could ...

The other experimental drug is bimagrumab, which is designed to help patients on weight loss medications from losing too much ...

Kalaris Therapeutics, Inc. reported improved Q3'25 results, with a net loss of $11.9M and $77M in cash. Click here to read why KLRS stock is a Buy.

“Following the initial pause, the FDA has placed the trial on a partial clinical hold,” the spokesperson explained.

This year saw notable progress in head and neck cancers, Huntington's disease, personalized genetic therapy, and heart ...

Objective To determine whether a full-scale randomised control trial (RCT) assessing the efficacy and cost-effectiveness of a ...

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure ...

Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...